Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity

被引:139
作者
Rogaeva, E
Premkumar, S
Song, YQ
Sorbi, S
Brindle, N
Paterson, A
Duara, R
Levesque, G
Yu, G
Nishimura, M
Ikeda, M
O'Toole, C
Kawarai, T
Jorge, R
Vilarino, D
Bruni, AC
Farrer, LA
St George-Hyslop, PH
机构
[1] Univ Toronto, Dept Med, Div Neurol, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada
[2] Univ Toronto, Clarke Inst Psychiat, Neurogenet Lab, Toronto, ON M5S 3H2, Canada
[3] Toronto Hosp, Dept Med, Div Neurol, Toronto, ON M5T 2S8, Canada
[4] Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA
[5] Mt Sinai Med Ctr, Dept Neurol, Miami Beach, FL 33140 USA
[6] Univ Florence, Dept Neurol & Psychiat, Firenze, Italy
[7] Univ Buenos Aires, Hosp Clin, Dept Neurol, Buenos Aires, DF, Argentina
[8] Ctr Reg Neurogenet ASL 6, Lamezia Terme, Italy
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 07期
关键词
D O I
10.1001/jama.280.7.614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context. - Alzheimer disease (AD) susceptibility genes have been identified on chromosomes 1, 14, 19, and 21, and a recent study has suggested a locus on chromosome 12. Objective. - To confirm or refute the existence of a familiar AD susceptibility locus on chromosome 12 in an independent sample of familial AD cases. Design.-Retrospective cohort study. DNA data for 6 chromosome 12 genetic markers were evaluated using parametric lod score and nonparametric linkage methods and linkage heterogeneity tests. The latter include the admixture test of homogeneity in the total group of families and the predivided sample test in families stratified by the presence or absence of an apolipoprotein E (APOE) epsilon 4 allele among affected members. Parametric analyses were repeated assuming autosomal dominant inheritance of AD and either age- and sex-dependent penetrance or zero penetrance for the analysis of unaffected relatives. Setting. - Clinical populations in the continental United States, Canada, Argentina, and Italy. Patients.-Fifty-three white families composed of multiple members affected with AD, from whom DNA samples were obtained from 173 patients with AD whose conditions were diagnosed using established criteria and from 146 nondemented relatives. Main Outcome Measure. - Presence of an APOE epsilon 4 allele among affected family members. Results. - Using parametric methods, no evidence for linkage to the region spanned by the chromosome 12 markers could be detected if familial AD is assumed to arise from the same genetic locus in all 53 families. However, significant evidence for linkage was detected in the presence of locus heterogeneity using the admixture test (odds ratio, 15, 135:1). The estimated proportion of linked families within the 53 families examined varied between 0.40 and 0.65, depending on the genetic model assumed and APOE status. The precise location of the AD gene could not be determined, but includes the entire region suggested previously. Nonparametric linkage analysis confirmed linkage to chromosome 12 with the strongest evidence at D12S96 (P < .001). Conclusions. - Our data provide independent confirmation of the existence of an AD susceptibility locus on chromosome 12 and suggest the existence of AD susceptibility genes on other chromosomes. Screening a larger set of families with additional chromosome markers will be necessary for identifying the chromosome 12 AD gene.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 44 条
[21]   Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP) [J].
Knauer, MF ;
Orlando, RA ;
Glabe, CG .
BRAIN RESEARCH, 1996, 740 (1-2) :6-14
[22]   LDL RECEPTOR-RELATED PROTEIN, A MULTIFUNCTIONAL APOE RECEPTOR, BINDS SECRETED BETA-AMYLOID PRECURSOR PROTEIN AND MEDIATES ITS DEGRADATION [J].
KOUNNAS, MZ ;
MOIR, RD ;
REBECK, GW ;
BUSH, AI ;
ARGRAVES, WS ;
TANZI, RE ;
HYMAN, BT ;
STRICKLAND, DK .
CELL, 1995, 82 (02) :331-340
[23]  
Kruglyak L, 1996, AM J HUM GENET, V58, P1347
[24]   GENETIC DISSECTION OF COMPLEX TRAITS - GUIDELINES FOR INTERPRETING AND REPORTING LINKAGE RESULTS [J].
LANDER, E ;
KRUGLYAK, L .
NATURE GENETICS, 1995, 11 (03) :241-247
[25]   Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population [J].
Lendon, CL ;
Talbot, CJ ;
Craddock, NJ ;
Han, SW ;
Wragg, M ;
Morris, JC ;
Goate, AM .
NEUROSCIENCE LETTERS, 1997, 222 (03) :187-190
[26]   CANDIDATE GENE FOR THE CHROMOSOME-1 FAMILIAL ALZHEIMERS-DISEASE LOCUS [J].
LEVYLAHAD, E ;
WASCO, W ;
POORKAJ, P ;
ROMANO, DM ;
OSHIMA, J ;
PETTINGELL, WH ;
YU, CE ;
JONDRO, PD ;
SCHMIDT, SD ;
WANG, K ;
CROWLEY, AC ;
FU, YH ;
GUENETTE, SY ;
GALAS, D ;
NEMENS, E ;
WIJSMAN, EM ;
BIRD, TD ;
SCHELLENBERG, GD ;
TANZI, RE .
SCIENCE, 1995, 269 (5226) :973-977
[27]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[28]   A PATHOGENIC MUTATION FOR PROBABLE ALZHEIMERS-DISEASE IN THE APP GENE AT THE N-TERMINUS OF BETA-AMYLOID [J].
MULLAN, M ;
CRAWFORD, F ;
AXELMAN, K ;
HOULDEN, H ;
LILIUS, L ;
WINBLAD, B ;
LANNFELT, L .
NATURE GENETICS, 1992, 1 (05) :345-347
[29]   APOE-EPSILON-4 AND EARLY-ONSET ALZHEIMERS [J].
OKUIZUMI, K ;
ONODERA, O ;
TANAKA, H ;
KOBAYASHI, H ;
TSUJI, S ;
TAKAHASHI, H ;
OYANAGI, K ;
SEKI, K ;
TANAKA, M ;
NARUSE, S ;
MIYATAKE, T ;
MIZUSAWA, H ;
KANAZAWA, I .
NATURE GENETICS, 1994, 7 (01) :10-11
[30]  
Ott J, 1991, ANAL HUMAN GENETIC L